211 related articles for article (PubMed ID: 33588233)
1. EBV as a high infection risk factor promotes RASSF10 methylation and induces cell proliferation in EBV-associated gastric cancer.
Gao Y; Fu Y; Wang J; Zheng X; Zhou J; Ma J
Biochem Biophys Res Commun; 2021 Apr; 547():1-8. PubMed ID: 33588233
[TBL] [Abstract][Full Text] [Related]
2. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
[TBL] [Abstract][Full Text] [Related]
5. Update on Epstein-Barr virus and gastric cancer (review).
Shinozaki-Ushiku A; Kunita A; Fukayama M
Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
[TBL] [Abstract][Full Text] [Related]
7. LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma.
Wang J; Liu W; Zhang X; Zhang Y; Xiao H; Luo B
Virology; 2019 Aug; 534():87-95. PubMed ID: 31220652
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
[No Abstract] [Full Text] [Related]
9. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
Han J; He D; Feng ZY; Ding YG; Shao CK
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
[TBL] [Abstract][Full Text] [Related]
11. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Fukayama M; Kunita A; Kaneda A
Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
13. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.
Chen JN; He D; Tang F; Shao CK
J Clin Gastroenterol; 2012 Apr; 46(4):262-71. PubMed ID: 22392024
[TBL] [Abstract][Full Text] [Related]
16. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.
Wang J; Zheng X; Qin Z; Wei L; Lu Y; Peng Q; Gao Y; Zhang X; Zhang X; Li Z; Fu Y; Liu P; Liu C; Yan Q; Xiong W; Li G; Lu J; Ma J
J Biol Chem; 2019 Mar; 294(13):4854-4866. PubMed ID: 30674552
[TBL] [Abstract][Full Text] [Related]
19. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.
Wang A; Zhang W; Jin M; Zhang J; Li S; Tong F; Zhou Y
Mol Med Rep; 2016 May; 13(5):4151-8. PubMed ID: 27052804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]